লোডিং…
The Survival Outcomes of T1aN0M0 Triple-Negative Breast Cancer With Adjuvant Chemotherapy
Purpose: Triple-negative breast cancer (TNBC) is a subtype with distinct heterogeneity, high invasiveness, and poorer prognosis. There is a controversy about adjuvant chemotherapy (ACT) at the T1aN0M0 stage. This study was carried out to assess the survival benefit of ACT for these patients. Methods...
| প্রধান লেখক: | , , , , |
|---|---|
| বিন্যাস: | Online প্রবন্ধ পাঠ্য |
| ভাষা: | English |
| প্রকাশিত: |
Frontiers Media S.A.
2020
|
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556218/ https://www.ncbi.nlm.nih.gov/pubmed/33102205 http://dx.doi.org/10.3389/fonc.2020.01753 |